OtsukaLtd. 

€56.5
0
-€1.5-2.59% Today

Statistics

Day High
57
Day Low
56.5
52W High
61.5
52W Low
37.6
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OS1.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap161.09B
Pfizer is a global pharmaceutical company that competes with Otsuka in various therapeutic areas, including psychiatric and neurological disorders.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson, through its pharmaceutical segment, competes directly with Otsuka in the development and marketing of drugs for various conditions.
Novartis
NVS
Mkt Cap297.32B
Novartis is a leading healthcare company that competes with Otsuka in several areas, including neuroscience and digital health solutions.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline competes with Otsuka in the pharmaceutical sector, particularly in the development of medications for psychiatric conditions.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie competes with Otsuka in the neuroscience domain, particularly in the development of treatments for psychiatric disorders.
Merck
MRK
Mkt Cap298.84B
Merck & Co. competes with Otsuka in the healthcare sector, focusing on pharmaceuticals that address critical areas of health.
Takeda Pharmaceutical
TAK
Mkt Cap59.2B
Takeda Pharmaceutical Company competes with Otsuka, especially in Japan and in the field of neuroscience, sharing a similar market focus.
Rogers
ROG
Mkt Cap1.88B
Roche Holding AG competes with Otsuka in the pharmaceutical and diagnostics sectors, particularly in areas like personalized healthcare.
Astrazeneca
AZN
Mkt Cap315.47B
AstraZeneca competes with Otsuka in various therapeutic areas, including the development of treatments for diseases in oncology and cardiovascular.
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Bristol Myers Squibb competes with Otsuka in the pharmaceutical sector, particularly in the development of innovative medicines for serious diseases.

About

Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a drinkable-liquid; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a household antiseptic medicine. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.
Show more...
CEO
Mr. Tatsuo Higuchi
Employees
33226
Country
JP
ISIN
JP3188220002

Listings

0 Comments

Share your thoughts

FAQ

What is OtsukaLtd. stock price today?
The current price of OS1.STU is €56.5 EUR — it has decreased by -2.59% in the past 24 hours. Watch OtsukaLtd. stock price performance more closely on the chart.
What is OtsukaLtd. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange OtsukaLtd. stocks are traded under the ticker OS1.STU.
Is OtsukaLtd. stock price growing?
OS1.STU stock has fallen by -8.13% compared to the previous week, the month change is a +3.67% rise, over the last year OtsukaLtd. has showed a +29% increase.
How many employees does OtsukaLtd. have?
As of April 10, 2026, the company has 33,226 employees.
In which sector is OtsukaLtd. located?
OtsukaLtd. operates in the Healthcare sector.
When did OtsukaLtd. complete a stock split?
OtsukaLtd. has not had any recent stock splits.
Where is OtsukaLtd. headquartered?
OtsukaLtd. is headquartered in Tokyo, JP.